抗 原: IRF6
技術(shù)規(guī)格
Background: |
This gene encodes a member of the interferon regulatory transcription factor (IRF) family. Family members share a highly-conserved N-terminal helix-turn-helix DNA-binding domain and a less conserved C-terminal protein-binding domain. The encoded protein may be a transcriptional activator. Mutations in this gene can cause van der Woude syndrome and popliteal pterygium syndrome. Mutations in this gene are also associated with non-syndromic orofacial cleft type 6. Alternate splicing results in multiple transcript variants. |
Applications: |
ELISA, WB, IHC |
Name of antibody: |
IRF6 |
Immunogen: |
Fusion protein of human IRF6 |
Full name: |
interferon regulatory factor 6 |
Synonyms: |
LPS; PIT; PPS; VWS; OFC6; PPS1; VWS1 |
SwissProt: |
O14896 |
ELISA Recommended dilution: |
1000-2000 |
IHC positive control: |
Human cervical cancer and human lung cancer |
IHC Recommend dilution: |
50-200 |
WB Predicted band size: |
53 kDa |
WB Positive control: |
Mouse kidney and lung tissue |
WB Recommended dilution: |
200-1000 |